Exploring the anti-tumor effect of silver nanoparticles in oral and skin cancer in vivo: Systematic review and meta-analysis
DOI:
https://doi.org/10.33448/rsd-v13i4.45505Keywords:
Silver compounds; Melanoma; Antineoplastic Agents.Abstract
This study aimed to analyze the in vivo anti-tumor effect of silver nanoparticles (AgNPs) against oral and skin cancer. The PRISMA guidelines were followed, and a registration in PROSPERO was performed. A search of databases was carried out in September 2023. The data were analyzed using the inverse variance method with a random effect model. All studies assessed anti-tumor efficacy against melanoma, and 21 days after treatment with AgNPs showed a reduction in tumor volume (SMD -6.58; PI [-9.82, -3.34]). Administration of AgNPs in injectable and topical form was effective in reducing tumors, erythema and preventing metastases without causing side effects. We concluded that AgNPs showed antitumor action against mice melanoma by reducing tumor volume and preventing cell proliferation and metastasis.
References
Alali, A., Hosseini-Abari, A., Bahrami, A., & Yazdan Mehr, M. (2023). Biosynthesis of Copper Oxide and Silver Nanoparticles by Bacillus Spores and Evaluation of the Feasibility of Their Use in Antimicrobial Paints. Materials (Basel), 16: 4670. https://doi.org/10.3390/ma16134670
Alamer, F. A., & Beyari, R. F. (2022). Overview of the Influence of Silver, Gold, and Titanium Nanoparticles on the Physical Properties of PEDOT:PSS-Coated Cotton Fabrics. Nanomaterials, 12:1609. https://doi.org/10.3390/nano12091609
Alkhalaf, M. I., Hussein, R. H., & Hamza, A. (2020). Green synthesis of silver nanoparticles by Nigella sativa extract alleviates diabetic neuropathy through anti-inflammatory and antioxidant effects. Saudi J Biol Sci, 27:2410–2419. https://doi.org/10.1016/j.sjbs.2020.05.005
Sanfelice, R. A. S., Silva, T. F., Tomiotto-Pellissier, F. et al. (2022). Biogenic silver nanoparticles reduce Toxoplasma gondii infection and proliferation in RAW 264.7 macrophages by inducing tumor necrosis factor-alpha and reactive oxygen species production in the cells. Microbes Infect, 24:104971. https://doi.org/10.1016/j.micinf.2022.104971
Bai, H., Bosch, J. J., & Heindl, L. M. (2023). Current management of uveal melanoma: A review. Clin Exp Ophthalmol, 51:484–494. https://doi.org/10.1111/ceo.14214
Bansod, S. D., Bawaskar, M. S., Gade, A. K., & Rai, M. K. (2015). Development of shampoo, soap and ointment formulated by green synthesised silver nanoparticles functionalised with antimicrobial plants oils in veterinary dermatology: Treatment and prevention strategies. IET Nanobiotechnology, 9:165–171. https://doi.org/10.1049/iet-nbt.2014.0042
Canaparo, R., Foglietta, F., Limongi, T., & Serpe L. (2021). Biomedical applications of reactive oxygen species generation by metal nanoparticles. Materials (Basel), 14:1–14. https://doi.org/10.3390/ma14010053
Danciu, C., Pinzaru, I., Coricovac, D. et al. (2019). Betulin silver nanoparticles qualify as efficient antimelanoma agents in in vitro and in vivo studies. Eur J Pharm Biopharm, 134:1–19. https://doi.org/10.1016/j.ejpb.2018.11.006
Drevon, D., Fursa, S. R., & Malcolm, A.L. (2017) Intercoder Reliability and Validity of WebPlotDigitizer in Extracting Graphed Data. Behav Modif, 41:323–339. https://doi.org/10.1177/0145445516673998
Gao, H., Fan, P., Xu, Q. et al. (2015). In Vitro and in Vivo Antitumor Activity of Silver Nanoparticles on B16 Melanoma. Nano, 15:1–14. https://doi.org/10.1142/S1793292020501635
Hooijmans, C. R., Rovers, M. M, De Vries, R. B. M., et al. (2014). SYRCLE’s risk of bias tool for animal studies. BMC Med Res Methodol, 14:1–9. https://doi.org/10.1186/1471-2288-14-43
Kaabipour, S., & Hemmati, S. (2021). A review on the green and sustainable synthesis of silver nanoparticles and one-dimensional silver nanostructures. Beilstein J Nanotechnol, 12:102–136.
Li, F., Zheng, Z., Chen, W. et al. (2023). Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms. Drug Resist Updat, 68:100938. https://doi.org/10.1016/j.drup.2023.100938
Li, Y., Liao, Q., Hou, W., & Qin, L. (2023). Silver-Based Surface Plasmon Sensors: Fabrication and Applications. Int J Mol Sci, 24: 4142. https://doi.org/10.3390/ijms24044142
Luo, D., Wan, X., Liu, J., & Tong T. (2018). Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res, 27:1785–1805. https://doi.org/10.1177/0962280216669183
Miranda, R. R., Sampaio, I., & Zucolotto, V. (2022). Exploring silver nanoparticles for cancer therapy and diagnosis. Colloids Surf B Biointerfaces, 210:112254. https://doi.org/10.1016/j.colsurfb.2021.112254
Ouzzani, M., Hammady, H., Fedorowicz, Z., & Elmagarmid, A. (2016). Rayyan-a web and mobile app for systematic reviews. Syst Rev, 5:1–10. https://doi.org/10.1186/s13643-016-0384-4
Page, M. J., McKenzie, J. E., Bossuyt, P. M., et al. (2021). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ, 29:372. https://doi.org/10.1136/bmj.n71
Parveen, A., Kulkarni, N., Yalagatti, M., Abbaraju, V., & Deshpande, R. (2018). In vivo efficacy of biocompatible silver nanoparticles cream for empirical wound healing. J Tissue Viability, 27:257–261. https://doi.org/10.1016/j.jtv.2018.08.007
Rana, K., Kumar, P. S., Chauhan, S., & Preet, S. (2022). Anticancer therapeutic potential of 5-fluorouracil and nisin co-loaded chitosan coated silver nanoparticles against murine skin cancer. Int J Pharm, 620:121744. https://doi.org/10.1016/j.ijpharm.2022.121744
Rashid, S., Shaughnessy, M., & Tsao, H. (2023). Melanoma classification and management in the era of molecular medicine. Dermatol Clin, 41:49–63. https://doi.org/10.1016/j.det.2022.07.017
Schwiebs, A., & Radeke, H. H. (2017). Immunopharmacological Activity of Betulin in Inflammation-associated Carcinogenesis. Anticancer Agents Med Chem, 18:645–651. https://doi.org/10.3390/plants10122663
Sergi, M. C., Filoni, E., Triggiano, G. et al. (2023). Mucosal Melanoma: Epidemiology, Clinical Features, and Treatment. Curr Oncol Rep, 1:0123456789. https://doi.org/10.1007/s11912-023-01453-x
Shabatina, T. I., Vernaya, O. I., Shimanovskiy, N. L., & Melnikov, M. Y. (2023). Metal and Metal Oxides Nanoparticles and Nanosystems in Anticancer and Antiviral Theragnostic Agents. Pharmaceutics, 15:118115. https://doi.org/10.3390/pharmaceutics15041181
Shinde, V. R., Revi, N., Murugappan, S., Singh, S. P., & Rengan, A. K. (2022). Enhanced permeability and retention effect: A key facilitator for solid tumor targeting by nanoparticles. Photodiagnosis Photodyn Ther, 39:102915. https://doi.org/10.1016/j.pdpdt.2022.102915
Siegel, R. L., Miller, K. D., Wagle, N. S., & Jemal, A. (2023). Cancer statistics, 2023. CA Cancer J Clin, 73:17–48. https://doi.org/10.3322/caac.21763
Sierra Rivera, C. A., Franco Molina, M. A., Mendoza Gamboa, E. et al. (2013). Potential of colloidal or silver nanoparticles to reduce the growth of B16F10 melanoma tumors. African J Microbiol 7:2745–2750. https://doi.org/10.5897/AJMR12.1968
Silva, J. M. C., Teixeira, A. B., & Reis, A. C. (2023). Silver-based gels for oral and skin infections: antimicrobial effect and physicochemical stability. Future Microbiol, 18:985-996. https://doi.org/10.2217/fmb-2023-0034
Sivadasan, D., Ramakrishnan, K., Mahendran, J. et al. (2023). Solid Lipid Nanoparticles: Applications and Prospects in Cancer Treatment. Int J Mol Sci, 24: 6199. https://doi.org/10.3390/ijms24076199
Tambunlertchai, S., Geary, S. M., Naguib, Y. W., & Salem, A. K. (2023). Investigating silver nanoparticles and resiquimod as a local melanoma treatment. Eur J Pharm Biopharm, 183:1–12. https://doi.org/10.1016/j.ejpb.2022.12.011
Torres-Cavazos, Z., Franco-Molina, M.A., Santana-Krímskaya, S. E. et al. (2020). In Vivo Evaluation of the Antitumor and Immunogenic Properties of Silver and Sodium Dichloroacetate Combination against Melanoma. J Nanomater, 741019. https://doi.org/10.1155/2020/3741019
Twilley, D., Thipe, V. C., Kishore, N. et al. (2022). Antiproliferative Activity of Buddleja saligna (Willd.) against Melanoma and In Vivo Modulation of Angiogenesis. Pharmaceuticals (Basel), 15:1497. https://doi.org/10.3390/ph15121497
Valenzuela-Salas, L. M., Girón-Vázquez, N. G., García-Ramos, J. C. et al. (2019). Antiproliferative and antitumour effect of nongenotoxic silver nanoparticles on melanoma models. Oxid Med Cell Longev, 25:4528241. https://doi.org/10.1155/2019/4528241
Wang, H., Tran, T. T., Duong, K. T. et al. (2022). Nguyen T, Le UM. Options of Therapeutics and Novel Delivery Systems of Drugs for the Treatment of Melanoma. Mol Pharm, 4487–4505. https://doi.org/10.1021/acs.molpharmaceut.2c00775
Zeng, L., Brignardello-Petersen, R., & Guyatt, G. (2021). When applying GRADE, how do we decide the target of certainty of evidence rating? Evid Based Ment Health, 24:121–123. https://doi.org/10.1136/ebmental-2020-300170
Zheng, D. X., Soldozy, S., Mulligan, K. M. et al. (2023). Epidemiology, management, and treatment outcomes of metastatic spinal melanoma. World Neurosurg, 18:100156. https://doi.org/10.1016%2Fj.wnsx.2023.100156
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 João Marcos Carvalho-Silva; Andréa Cândido dos Reis
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
